| 000 | 01630 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513112119.0 | ||
| 264 | 0 | _c19970305 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/s0024-3205(96)00665-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFilippelli, A | |
| 245 | 0 | 0 |
_aTransglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. _h[electronic resource] |
| 260 |
_bLife sciences _c1997 |
||
| 300 |
_a403-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAndrostanes _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurokinin A _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPhysalaemin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPortal Vein _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstance P _xanalogs & derivatives |
| 650 | 0 | 4 |
_aThiorphan _xpharmacology |
| 650 | 0 | 4 |
_aTransglutaminases _xmetabolism |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 700 | 1 | _aEsposito, C | |
| 700 | 1 | _aFalciani, M | |
| 700 | 1 | _aCosta, C | |
| 700 | 1 | _aCozzolino, A | |
| 700 | 1 | _aRossi, F | |
| 700 | 1 | _aPorta, R | |
| 773 | 0 |
_tLife sciences _gvol. 60 _gno. 6 _gp. 403-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0024-3205(96)00665-0 _zAvailable from publisher's website |
| 999 |
_c9020902 _d9020902 |
||